Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentUnknown
NCT04276623N/AUpdated Nov 29, 2023
Sponsor: UMC Utrecht
Atopic Dermatitis
Netherlands
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesCompleted
NCT05214326N/AUpdated Nov 29, 2023
Sponsor: Sanofi
Dermatitis Atopic
Kuwait, Saudi Arabia, United Arab Emirates
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompleted
NCT00697684Phase 1Updated Nov 28, 2023
Sponsor: Beth Israel Deaconess Medical Center
Acute Myeloid Leukemia · Myelodysplastic Syndrome · Acute Lymphocytic Leukemia · Relapsed/Refractory Chronic Lymphocytic Leukemia
United States
A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male ParticipantsCompleted
NCT06143904Phase 1Updated Nov 22, 2023
Sponsor: Sanofi
Gaucher's Disease Type I
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and OlderCompleted
NCT06118151Phase 1Updated Nov 7, 2023
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza · Influenza Immunization
United States
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United KingdomCompleted
NCT03632720Phase 3Updated Nov 7, 2023
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Meningococcal Infection)
United Kingdom
Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult ParticipantsCompleted
NCT06106074Phase 1Updated Oct 30, 2023
Sponsor: Sanofi
Multiple Sclerosis
United States
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and MexicoCompleted
NCT03630705Phase 3Updated Oct 19, 2023
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Meningococcal Infection)
Mexico, Russia
Open-label Study of Dupilumab in Patients With Atopic DermatitisCompleted
NCT01949311Phase 3Updated Oct 17, 2023
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
United States, Australia, Austria, Belgium, Bulgaria +23 more
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple MyelomaRecruiting
NCT04558931Phase 2Updated Oct 11, 2023
Sponsor: Karolinska Institutet
Multiple Myeloma
Sweden
Leukine (Sargramostim) for Parkinson's DiseaseCompleted
NCT01882010Phase 1Updated Oct 6, 2023
Sponsor: University of Nebraska
Parkinson's Disease
United States
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale CanadaRecruiting
NCT02009345N/AUpdated Oct 4, 2023
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Familial Hypercholesterolemia · Lipid Disorder
Canada
Real Life Experience Survey of Dupilumab in the NetherlandsCompleted
NCT05331755N/AUpdated Sep 21, 2023
Sponsor: Gert-Jan Braunstahl
Severe Asthma
Netherlands
Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information UpdateCompleted
NCT04170140N/AUpdated Sep 18, 2023
Sponsor: Sanofi Pasteur, a Sanofi Company
Dengue Virus Infection
France
Improved Induction and Maintenance Immunosuppression in Kidney TransplantationCompleted
NCT00556933Phase 4Updated Sep 18, 2023
Sponsor: University of Nebraska
End-stage Renal Disease
United States
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous PlerixaforCompleted
NCT01696461Phase 2Updated Sep 14, 2023
Sponsor: Center for International Blood and Marrow Transplant Research
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member · Acute Myelogenous Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndrome
United States
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell CarcinomaWithdrawn
NCT05535023Phase 2Updated Sep 13, 2023
Sponsor: M.D. Anderson Cancer Center
Squamous Cell Carcinoma · Oropharynx Cancer · Head and Neck Cancer
United States
The Optimization of Haploidentical Hematopoietic Stem Cell TransplantationUnknown
NCT05629260N/AUpdated Sep 11, 2023
Sponsor: Peking University People's Hospital
Hematological Malignancy
China
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompleted
NCT05203380N/AUpdated Sep 8, 2023
Sponsor: Regeneron Pharmaceuticals
Moderate-to-severe Atopic Dermatitis
United States
Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple MyelomaCompleted
NCT03733717Phase 1Updated Sep 8, 2023
Sponsor: Sanofi
Multiple Myeloma
China
Cholinergic Urticaria - Efficacy of DupilumabCompleted
NCT03749148Phase 2Updated Sep 6, 2023
Sponsor: Charite University, Berlin, Germany
Cholinergic Urticaria
Germany
Physical and Cognitive Performance During the Two First Years of Lemtrada TreatmentCompleted
NCT03806387N/AUpdated Sep 6, 2023
Sponsor: University of Aarhus
Multiple Sclerosis
Denmark
KD025 in Subjects With Diffuse Cutaneous Systemic SclerosisTerminated
NCT03919799Phase 2Updated Aug 30, 2023
Sponsor: Kadmon, a Sanofi Company
System; Sclerosis · Diffuse Cutaneous Systemic Sclerosis
United States
Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)Completed
NCT01511068Phase 2Updated Aug 30, 2023
Sponsor: Children's Hospital Medical Center, Cincinnati
Hereditary Pulmonary Alveolar Proteinosis
United States
An Observational Study on Teriflunomide-exposed PregnanciesCompleted
NCT03198351N/AUpdated Aug 28, 2023
Sponsor: Sanofi
Multiple Sclerosis
United States, Canada

Previous page Next page